Recurrence of differentiated thyroid carcinoma without concomitant elevation of serum thyroglobulin. Report of two cases;Tiroglobulina y sus limitaciones en el seguimiento del carcinoma diferenciado del tiroides

Revista Medica de Chile

Volumn 135, Issue 4, 2007, Pages 506-511

  Velasco L, Soledad ^a   Solar G, Antonieta ^a   Cruz O, Francisco ^a   Quintana F, Juan Carlos ^a   León R, Augusto ^b   Mosso G, Lorena ^a   Fardella B, Carlos ^a,c  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c NONE

Author keywords

Carcinoma, papillary; Thyroglobulin; Thyroid neoplasms

Indexed keywords

THYROGLOBULIN; TUMOR MARKER;

ADULT; ARTICLE; BIOPSY; BLOOD; CASE REPORT; FEMALE; HUMAN; MALE; METASTASIS; MIDDLE AGED; PAPILLARY CARCINOMA; PATHOLOGY; THYROID TUMOR; TUMOR RECURRENCE;

ADULT; BIOPSY; CARCINOMA, PAPILLARY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; THYROGLOBULIN; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34249045425     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. LANDIS SH, MURRAY T, BOLDEN S, WINGO PA. Cancer statistics, CA Cancer. J Clin 1998; 48: 6-29.
2. FARDELLA C, JIMÉNEZ M, GONZÁLEZ H, LEÓN A, GOÑI I, CRUZ F ET AL. Características de presentación del microcarcinoma papilar del tiroides. Experiencia retrospectiva de los últimos 12 años de la Pontificia Universidad Católica de Chile. Rev Méd Chile 2005; 133: 1305-10.
3. th ed, 2005; 345-53.
4. VAN DE GRAAF SAR, RIS-S TALPERS C, PAUWS E, MENDIVE FM, TARGOVNIK HM, DE VIJLDER JJM. Up to date with human thyroglobulin. J Endocrinol 2001; 170: 307-21.
5. MAZZAFERRI E, ROBBINS R, SPENCER C, BRAVERMAN L, PACINI F, WARTOFSKY L ET AL. A Consensus Report of the Role of Serum Thyroglobulin as a Monitoring Method for Low-Risk Patients with Papillary Thyroid Carcinoma. J Clin Endocrinol Metab 2003; 88: 1433-41.
6. BACHELOT A, LEBOULLEUX S, BAUDIN E, HARTL D, CAILLOU B, TRAVAGLI J ET AL. Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment. Clin Endocrinol (Oxf) 2005; 62: 376-9.
7. ROBBINS R, CHON J, FLEISHER M, LARSON S, TUTTLE M. Is the Serum Thyroglobulin Response to Recombinant Human Thyrotropin Sufficient, by Itself, to Monitor for Residual Thyroid Carcinoma? J Clin Endocrinol Metab 2001; 87: 3242-7.
8. COOPER DS, DOHERTY G, HAUGEN B, KLOOS R, LEE S, MANDEL S ET AL. Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2006; 16: 1-34.
9. SPENCER CA, BERGOGLIO LM, KAZAROSYAN M, FATEMI S, LOPRESTI JS. Clinical Impact of Thyroglobulin (Tg) and Tg Autoantibody Method Differences on the Management of Patients with Differentiated Thyroid Carcinomas. J Clin Endocrinol Metab 2005; 90: 5566-75.
10. SPENCER CA, TAKEUCHI M, KAZAROSYAN M, WANG CC, GUTTLER RB, SINGER PA ET AL. Serum Thyroglobulin Autoantibodies: Prevalence, Influence on Serum Thyroglobulin Measurement, and Prognostic Significance in Patients with Differentiated Thyroid Carcinoma. J Clin Endocrinol Metab 1998; 83: 1121-7.
11. BASOLO F, PISATURO F, POLLINA LE, FONTANINI G, ELISEI R, MOLINARO E ET AL. N-ras Mutation in Poorly Differentiated Thyroid Carcinomas: Correlation with Bone Metastases and Inverse Correlation to Thyroglobulin Expression. Thyroid 2000; 10: 19-23.
12. BACHELOT A, CAILLEUX AF, KLAIN M, BAUDIN E, RICARD M, BELLON N ET AL. Relationship Between Tumor Burden and Serum Thyroglobulin Level in Patients with Papillary and Follicular Thyroid Carcinoma. Thyroid 2002; 12: 707-11.
13. DRALLE H, SCHWARZROCK R, LANG W, BOCKER W, ZIEGLER H, SCHRODER S ET AL. Comparison of histology and immunohistochemistry with thyroglobulin serum levels and radioiodine uptake in recurrences and metastases of differentiated thyroid carcinomas. Acta Endocrinol 1985; 108: 504-10.
14. MURESAN Z, ARVAN P. Enhanced Binding to the Molecular Chaperone BiP Slows Thyroglobulin Export from the Endoplasmic Reticulum. Mol Endocrinol 1998; 12: 458-67.
15. MARINÓ M, PINCHERA A, MCCLUSKEY R, CHIOVATO L. Megalin in Thyroid Physiology and Pathology. Thyroid 2001; 11: 47-56.
16. FRASOLDATI A, PESENTI M, GALLO M, CAROGGIO A, SALVO D, VALCAVI R. Diagnosis of Neck Recurrences in Patients with Differentiated Thyroid Carcinoma. Cancer 2003; 97: 90-6.
17. BASKIN HJ. Detection of recurrent papillary thyroid carcinoma by thyroglobulin assessment in the needle washout after fine-needle aspiration of suspicious lymph nodes. Thyroid 2004; 14: 959-63.
18. CIGNARELLI M, AMBROSI A, MARINO A, LAMACCHIA O, CAMPO M, PICCA G ET AL. Diagnostic utility of thyroglobulin detection in fine-needle aspiration of cervical cystic metastatic lymph nodes from papillary thyroid cancer with negative cytology. Thyroid 2003; 13: 1163-7.
19. SABOORI AM, ROSE NR, BRESLER HS, VLADUT-TALOR M, BUREK CL. Iodination of human thyroglobulin (Tg) alters its immunoreactivity. Clin Exp Immunol 1998; 113: 297-302.
20. KIM PS, DUNN AD, DUNN JT. Altered Immunoreactivity of Thyroglobulin in Thyroid Disease. J Clin Endocrinol Metab 1988; 67: 161-8.
21. BERTAUX F, NOEL M, LASMOLES F, FRAGU P. Identification of the exon structure and four alternative transcripts of the thyroglobulin-encoding gene. Gene 1995; 156: 297-301.
22. SPENCER CA, TAKEUCHI M, KAZAROSYAN M. Current status and performance goals for serum thyroglobulin assays. Clin Chem 1996; 42: 164-73.
23. BALOCH Z, CARAYON P, CONTE-DEVOLX B, DEMERS L, FELDT-RASMUSSEN U, HENRY JF ET AL. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003; 13: 3-126.